 ISFIYA, Israel, March 19, 2021 PRNewswire -- Check-Cap Ltd. the Company or Check-Cap NASDAQ: CHEK, NASDAQ: CHEKZ, a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only patient-friendly, preparation-free, screening test to detect polyps before they may transform into colorectal cancer CRC, today announced financial results for the fourth quarter and full year ended December 31, 2020. 